Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer.

Intravesical therapy with Bacillus Calmette-Guerin (BCG) aims to reduce the incidence of tumour recurrence following transurethral resection (TUR) for patients with superficial bladder cancer.